Endothelial cell dysfunction after coronary artery bypass grafting with extracorporeal circulation in patients with
Karla Lehle1, Jürgen G Preuner, Anja Vogt
1Department of Cardiothoracic Surgery, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, D-93053 Regensburg, Germany. Karla.Lehle@klinik.uni-regensburg.de
Insights
Type 2 diabetes mellitus patients undergoing coronary artery bypass grafting (CABG) show specific endothelial dysfunction. Diabetic patients exhibit impaired interleukin-6 (IL-6) release and increased E-selectin turnover post-CABG.
Area of Science:
- Cardiovascular Surgery
- Endocrinology
- Immunology
Background:
- Type 2 diabetes mellitus is a significant risk factor for severe coronary artery disease.
- Coronary artery bypass grafting (CABG) is a common surgical intervention for severe coronary artery disease.
- Endothelial dysfunction is a key pathological process in cardiovascular disease.
Purpose of the Study:
- To investigate endothelial dysfunction in patients with type 2 diabetes mellitus undergoing CABG.
- To evaluate the release of soluble inflammatory cytokines, specifically E-selectin, interleukin-6 (IL-6), and tumor necrosis factor (TNF), postoperatively.
- To analyze the kinetic profiles of these cytokines in diabetic versus non-diabetic patients.
Main Methods:
- A comparative study of patients undergoing CABG, divided into two groups: without diabetes (n=15) and with type 2 diabetes mellitus (n=14).
- Postoperative measurement of E-selectin, IL-6, and TNF levels up to 3 days.
- Pharmacokinetic analysis using a non-compartmental model to determine maximum concentrations (c(max)), time to reach c(max) (t(max)), area under the curve (AUC(0-inf)), and terminal elimination half-time (t(1/2)).
Main Results:
- No significant differences in preoperative cytokine levels or postoperative TNF kinetics between groups.
- Diabetic patients (group B) showed significantly restricted IL-6 release (lower c(max) and AUC(0-inf)) compared to non-diabetic patients (group A).
- E-selectin showed a significantly decreased AUC(0-inf) and reduced t(1/2) in diabetic patients, suggesting increased endothelial uptake and degradation.
Conclusions:
- Coronary artery bypass grafting with extracorporeal circulation can reveal specific endothelial dysfunction in diabetic patients.
- This dysfunction is characterized by impaired IL-6 release and augmented E-selectin turnover.
- Findings highlight the distinct inflammatory and endothelial responses in diabetic patients undergoing CABG.
Objective:
Type 2 diabetes mellitus is a well-known risk factor in patients with severe coronary artery disease undergoing coronary artery bypass grafting (CABG). The aim of the study was to analyze the endothelial dysfunction in these patients by evaluating postoperative soluble inflammatory cytokines.
Methods:
Patients undergoing CABG without (n=15, group A) and with (n=14, group B) diabetes mellitus were analyzed for their release of E-selectin, interleukin-6 (IL-6), and tumor necrosis factor (TNF) up to 3 days postoperatively. A pharmacokinetic quantitative kinetic evaluation (Kinetica 2000) of maximum concentrations (c(max)), time to reach c(max) (t(max)), area under the curve (AUC(0-inf)), and terminal elimination half time (t(1/2)) was performed using a non-compartmental model.
Results:
There was no difference in preoperative plasma concentrations of the cytokines and in the postoperative kinetic analyses of TNF when comparing both groups. However, the release of IL-6 was restricted with c(max) of 1055+/-543 pg/ml for group B versus 2112+/-1532 pg/ml for group A (p< or =0.05), paralleled by a decrease in the absolute amount (AUC(0-inf)) of IL-6. The t(1/2) remained unaffected (13.9+/-6.6h and 12.7+/-4.6h, respectively). The AUC(0-inf) of E-selectin decreased by a factor of 1.7 (p< or =0.05) with unchanged c(max) but reduced t(1/2) (12.9+/-10h for group B vs 33.1+/-20.4h for group A; p< or =0.01) referring to an augmented endothelial uptake and degradation of E-selectin.
Conclusions:
CABG with extracorporeal circulation could be used to verify a specific endothelial dysfunction in diabetic patients characterized by an impaired release of IL-6 and an increased turnover of E-selectin.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Coronary Artery Disease II: Pathophysiology
Diabetic Retinopathy
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Peripheral Artery Disease V: Postoperative Nursing Management
